webinar register page

RedChip Investor Group Call with Odyssey Health Inc. (OTC: ODYY)
Odyssey Health Inc. (formerly Odyssey Group International, Inc.) is a technology and asset acquisition company with a focus in the area of life saving medical solutions.

Odyssey’s novel pharmaceutical compound, PRV-002, is intended for the treatment of concussion. PRV-002 is a new chemical entity administered nasally with proven in-vivo efficacy and safety in concussion models. Pre-clinical results show significantly improved sensory motor function and significantly improved memory scores. The drug is currently in a Phase 1 human trial.


* Required information